Take a trial of UK to unlock this pageFind out more

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Mar 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 23rd Jul, paid: 21st Aug more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +5.2%

FINANCIAL BRIEF: For the fiscal year ended 31 March 2015, Immunodiagnostic Systems Hldgs PLC revenues decreased 13% to L45.4M. Net income decreased 66% to L2.4M. Revenues reflect USA Direct segment decrease of 24% to L12.2M, France segment decrease of 28% to L4.1M. Dividend per share decreased from L0.09 to L0.03. Basic Earnings per Share excluding Extraordinary Items decreased from L0.24 to L0.08. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
B-
B-
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Mar '15) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Mar 2016
31st Mar 2017

Price Target: 2.83
(-7.41% below Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
2 brokers Broker Consensus Trend
Broker Recommendations for Immunodiagnostic Systems Holdings
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 1 2 0 0

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity Julie Simmonds , Panmure Gordon Savvas Neophytou , Peel Hunt Charles Hall , Edison Investment Research John Savin , Daniel Stewart , N+1 Singer , FinnCap ,

Profile Summary

Immunodiagnostic Systems Holdings PLC is a solution provider for specialty testing in immunodiagnostics. Through its subsidiaries, the Company is also engaged in developing, manufacturing and distributing medical diagnostic products; manufacturing diagnostic test kits, and developing, manufacturing and distributing automated instruments and the distribution of its products in France and Belgium. The Company offers IDS-iSYS instrument platform is an instrument based on Chemiluminescence and Absorbency technology. The Company's IDS-iSYS platform is focused on a range of clinical areas, including bone metabolism, calcium metabolism, hypertension, chronic kidney disease and growth. The Company's subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Inc, Immunodiagnostic Systems Deutschland GmbH, Suomen Bioanalytiikka Oy (SBA Sciences Ltd), Immunodiagnostic Systems Nordic A/S, Immunodiagnostic Systems SA, ImmunoDiagnostic Systems France SAS and MGP Diagnostics AS.

Directors: Carlos Zando (CEO) 49, Andrew Davison (SEC) , Burkhard Wittek (NEC) , Till Campe (NED) 24, Peter Williamson (NED) 49, Roland Sackers (NID) 46,

No. of Employees: 336 No. of Shareholders: n/a


Last Annual March 31st, 2015
Last Interim March 31st, 2015
Incorporated June 4, 2004
Shares in Issue 29,161,915
Free Float 20.9m (71.8%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Intl-aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

IDH Share Price Performance IDHQuote
306p
0.0  0.0%
Traded 2:46pm · Minimum 15 min delayed · NMS: 0.500k

Latest IDH News Announcements (delayed)

Upcoming IDH Events

Recent ↓
Thursday 23rd July, 2015
Dividend For IDH.L
Tuesday 25th November, 2014
Half Year 2014 Immunodiagnostic Systems Holdings PLC Earnings Release
Tuesday 14th October, 2014
Half Year 2014 Immunodiagnostic Systems Holdings PLC Trading Statement Release
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Annual Shareholders Meeting
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Trading Statement
Wednesday 23rd July, 2014
Dividend For IDH.L
Tuesday 24th June, 2014
Full Year 2013 Immunodiagnostic Systems Holdings PLC Earnings Release


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.


Should you buy IDH

Access IDH Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis
Foliobuilder